SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-026730
Filing Date
2021-02-23
Accepted
2021-02-23 16:18:28
Documents
38
Period of Report
2021-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm217255d1_8k.htm   iXBRL 8-K 30832
2 EXHIBIT 99.1 tm217255d1_ex99-1.htm EX-99.1 122848
3 EXHIBIT 99.2 tm217255d1_ex99-2.htm EX-99.2 31780
7 GRAPHIC tm217255d1_ex99-1img01.jpg GRAPHIC 14036
8 GRAPHIC tm217255d1_ex99-2img001.jpg GRAPHIC 73316
9 GRAPHIC tm217255d1_ex99-2img002.jpg GRAPHIC 171062
10 GRAPHIC tm217255d1_ex99-2img003.jpg GRAPHIC 62569
11 GRAPHIC tm217255d1_ex99-2img004.jpg GRAPHIC 93938
12 GRAPHIC tm217255d1_ex99-2img005.jpg GRAPHIC 86125
13 GRAPHIC tm217255d1_ex99-2img006.jpg GRAPHIC 85161
14 GRAPHIC tm217255d1_ex99-2img007.jpg GRAPHIC 60876
15 GRAPHIC tm217255d1_ex99-2img008.jpg GRAPHIC 69619
16 GRAPHIC tm217255d1_ex99-2img009.jpg GRAPHIC 79138
17 GRAPHIC tm217255d1_ex99-2img010.jpg GRAPHIC 90019
18 GRAPHIC tm217255d1_ex99-2img011.jpg GRAPHIC 87179
19 GRAPHIC tm217255d1_ex99-2img012.jpg GRAPHIC 91418
20 GRAPHIC tm217255d1_ex99-2img013.jpg GRAPHIC 77190
21 GRAPHIC tm217255d1_ex99-2img014.jpg GRAPHIC 58231
22 GRAPHIC tm217255d1_ex99-2img015.jpg GRAPHIC 64142
23 GRAPHIC tm217255d1_ex99-2img016.jpg GRAPHIC 91695
24 GRAPHIC tm217255d1_ex99-2img017.jpg GRAPHIC 46541
25 GRAPHIC tm217255d1_ex99-2img018.jpg GRAPHIC 72598
26 GRAPHIC tm217255d1_ex99-2img019.jpg GRAPHIC 56867
27 GRAPHIC tm217255d1_ex99-2img020.jpg GRAPHIC 129661
28 GRAPHIC tm217255d1_ex99-2img021.jpg GRAPHIC 62104
29 GRAPHIC tm217255d1_ex99-2img022.jpg GRAPHIC 69619
30 GRAPHIC tm217255d1_ex99-2img023.jpg GRAPHIC 49894
  Complete submission text file 0001104659-21-026730.txt   2926725

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20210223.xsd EX-101.SCH 3193
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20210223_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20210223_pre.xml EX-101.PRE 22715
31 EXTRACTED XBRL INSTANCE DOCUMENT tm217255d1_8k_htm.xml XML 3629
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 21665680
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences